This report gives an overview of the tool and presents data from 2013/14 to 2017/18, showing how spend on diabetes medications and the proportion of patients achieving recommended blood glucose levels varies between general practices (GPs) and clinical commissioning groups
This paper reports on trends in life expectancy in the 28 EU countries and some other high-income OECD countries, and examines potential explanations for the slowdown in improvements in recent years. The slowdown in improvements in life expectancy since 2011
This handbook describes what local health and care systems can do to transform diabetes elective care services at pace, why this is necessary and how the impact of this transformation can be measured. Practical guidance for implementing and adopting a range
The findings in this report relate to the quality assurance visit of the Leicester, Leicestershire and Rutland screening service held on 5 June 2018.
Executive summary of quality assurance (QA) visit to Gloucestershire held on 6 June 2018.
The findings in this report relate to the quality assurance (QA) visit of the West Riding and Craven screening service held on 19 April 2018.
Cardiovascular disease (CVD) prevention is a major public health priority in England. The NHS RightCare Optimal Pathway has highlighted 6 CVD high-risk conditions that are currently under-diagnosed and insufficiently managed despite a range of available interventions, and therefore represent targets
The findings in this report relate to the quality assurance visit of the Oxfordshire Diabetic Eye Screening service held on 21 February 2018.
The number of people with multiple long-term conditions, known as multimorbidity, is rising internationally, putting increased pressure on health care systems, including the NHS. Researchers from the 3D Study – the largest ever trial of a person-centred approach to caring
This report assesses cardiovascular disease in the South West. It focuses on risk factors, heart disease, stroke, kidney disease and diabetes. It is aimed at commissioners and providers of health care services in the South West. It collects available data and evidence,
The case for adopting Neuropad to detect preclinical diabetic peripheral neuropathy is not supported by the evidence. Neuropad detects sub-normal sweating in patients with diabetes but the clinical importance of this in current NHS care pathways is poorly defined. There
This letter from Dr Partha Kar, NHS England Deputy National Clinical Director for Diabetes, highlights the nhs.uk online diabetes resource which provides practical information at diagnosis, such as videos on how to inject insulin, how to check blood glucose levels
The findings in this report relate to the quality assurance visit of the North Mersey diabetic eye screening service 18 January 2018. The QA visit team identified 3 high priority findings: a screening backlog in Southport and Ormskirk NHS Trust lack
Early treatment and intervention can greatly reduce the risk of complications and reduce health service expenditure, as well as improving quality of life for those with diabetes, so early intervention in this area is vital. This report looks at interventions to reduce emergency
This review and behavioural analysis of group based weight management programmes, identifies the: main factors (barriers and facilitators) that affect whether people take up weight management programmes main factors (barriers and facilitators) influencing continued engagement with programmes components of programme
This guide provides practical examples of language that will encourage positive interactions with people living with diabetes and subsequently positive outcomes.
Good eye health will enable people to live as independently as possible, have a high quality of life and save the cost of avoidable visual loss. As well as providing an overview of population need in the region and eye
Executive summary of quality assurance (QA) visit to North West London Diabetic Eye Screening Programme held on 8 February 2017. It makes one high priority recommendation: review the exclusions management process and ensure that the governance arrangements are explicit
This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Vale of York CCG area. This can help with planning, commissioning and improving local services. The pack uses GP practice data on prevention, detection and management